ARV-393 - Arvinas
Rituxan (rituximab) - Roche
Venclexta (venetoclax) - Roche, AbbVie
lenalidomide - Generic mfg.
Calquence (acalabrutinib) - AstraZeneca
Monjuvi (tafasitamab-cxix) - Incyte
Polivy (polatuzumab vedotin-piiq) - Roche
Tazverik (tazemetostat) - Ipsen
https://clml-25-01.elsevierdigitaledition.com/
 
Anna Van Acker PhD; Lynn DeCarr MS; Sarah Eaton MS; Dan Sherman BS; Mark Bookbinder MS; Elizabeth Bortolon MLS; Jennifer Pizzano BS; Morena Scopel PhD; William Corwin PhD; Ignacio Juncadella PhD; Yongqing Huang PhD; Ram Lingamaneni MS; Stephanie Renzullo MS; Jennifer Cantley PhD; XiaoZhe (Janet) Wang PhD; Ian Taylor PhD; Sean Landrette PhD; Sheryl M. Gough PhD
 
Aug 26, 2025
 
Next